未登录

X

Xuexin He

zhe jiang university

H指数:15

被引数:1,051

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term overall survival of patients who undergo breast-conserving therapy or mastectomy for early operable HER2-Positive breast cancer after preoperative systemic therapy: an observational cohort study

LANCET REGIONAL HEALTH-AMERICAS

IF7.6

2024-04-012

OAAI

[18F]FDG PET/MRI combined with chest HRCT in early cancer detection: a retrospective study of 3020 asymptomatic subjects (Jul, 10.1007/s00259-023-06273-6, 2023)

European Journal of Nuclear Medicine and Molecular Imaging

IF7.6

2023-08-230

OAAI

Stacking Ensemble Learning-Based [18F]FDG PET Radiomics for Outcome Prediction in Diffuse Large B-Cell Lymphoma

基于堆叠集成学习的 [18F]FDG PET影像组学用于弥漫性大b细胞淋巴瘤的结果预测

JOURNAL OF NUCLEAR MEDICINE

IF9.1

2023-07-2710

OA

[18F]FDG PET/MRI combined with chest HRCT in early cancer detection: a retrospective study of 3020 asymptomatic subjects

European Journal of Nuclear Medicine and Molecular Imaging

IF7.6

2023-07-043

OAAI

Enhanced Therapeutic Efficacy of Combining Losartan and Chemo-Immunotherapy for Triple Negative Breast Cancer

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-06-2324

OAAI

Positron Emission Tomography Molecular Imaging for Phenotyping and Management of Lymphoma

IF6.2

2022-02-249

OA

A novel analytic approach for outcome prediction in diffuse large B-cell lymphoma by [18F]FDG PET/CT

[18F]FDG PET/CT预测弥漫性大b细胞淋巴瘤预后的新分析方法

European Journal of Nuclear Medicine and Molecular Imaging

IF7.6

2021-10-1529

OAAI

Genomic characterization and outcome evaluation of kinome fusions in lung cancer revealed novel druggable fusions

NPJ PRECISION ONCOLOGY

IF8

2021-09-1018

OAAI

Association of Cardiovascular Disease Risk Factors with Late Cardiotoxicity and Survival in HER2-positive Breast Cancer Survivors

CLINICAL CANCER RESEARCH

IF10.2

2021-06-110

OA

Transpathology: molecular imaging-based pathology

European Journal of Nuclear Medicine and Molecular Imaging

IF7.6

2021-02-1371

OAAI

Long-Term Survival Analysis of Adjuvant Chemotherapy with or without Trastuzumab in Patients with T1, Node-Negative HER2-Positive Breast Cancer

CLINICAL CANCER RESEARCH

IF10.2

2019-12-1314

OAAI

The evolving role of trastuzumab emtansine (T-DM1) in HER2-positive breast cancer with brain metastases

曲妥珠单抗emtansine (T-DM1) 在HER2-positive乳腺癌脑转移中的作用

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

IF5.6

2019-11-0117

PREAI

Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis

BREAST CANCER RESEARCH AND TREATMENT

IF3

2018-10-1955

PREAI

Bortezomib enhances the therapeutic efficacy of dasatinib by promoting c-KIT internalization-induced apoptosis in gastrointestinal stromal tumor cells

IF10.1

2015-05-0111

PREAI

Small-animal PET demonstrates brain metabolic change after using bevacizumab in a rat model of cerebral ischemic injury

NEUROSCIENCE BULLETIN

IF5.8

2014-09-285

OAAI

Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+breast cancer

二甲双胍和噻唑烷二酮类药物与患有HER2乳腺癌的糖尿病女性乳腺癌特异性生存率改善相关

ANNALS OF ONCOLOGY

IF65.4

2012-07-01178

OAAI

Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients

ANNALS OF ONCOLOGY

IF65.4

2011-12-01134

OAAI

A pharmacokinetic and safety study of single dose intravenous combretastatin A4 phosphate in Chinese patients with refractory solid tumours

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2011-05-1235

OAAI